The embryonic neuroepithelium gives rise to the components of the central nervous system in the mature animal.
It is now well established that protein-tyrosine kinases (PTKs) play an important role in the regulation of cellular growth (1) . This family of proteins comprises two broad groups. The first group includes cell-surface receptors that mediate the activity of known growth factors, such as epidermal growth factor (2), platelet-derived growth factor (3) , and colony stimulating factor 1 (4) . The extracellular domain of each member of this class of PTKs interacts with its respective ligand, activating the PTK activity of the intracellular part of the molecule, which in turn initiates the mitogenic response of the cell. The second group of PTKs is comprised of proteins that lack the extracellular domain of the growth factor receptor family and are frequently associated with the inner surface, the plasma membrane, or other intracellular structures. This latter class is typified by the c-src, c-abl, and c-fes protooncogenes (5) (6) (7) . The regulation of these PTKs is not yet understood. Many of these proteins were first identified as the transforming proteins of retroviruses and have also been implicated in some human and murine cancers (8, 9) .
In studying early development of the central nervous system (CNS), we have attempted to isolate growth factors and their receptors that are involved in the growth and differentiation of neuroepithelial cells of the neural tube of 10-day-old mouse embryos (E10) into neuronal and glial cells. That basic and acidic fibroblast growth factors (FGFs) stimulate the growth of mesoderm-and neuroectoderm-derived cells has been demonstrated (10) (11) (12) (13) (14) . These growth factors support the growth and differentiation of E10 neuroepithelial cells, as well as survival of some neurons from different regions of the central and peripheral nervous systems.
The FGFs may, therefore, be involved in the embryonic development of the CNS. The FGF family consists of at least seven members (15) (16) (17) (18) (19) (20) , all of which are structurally related. Further, most of them bind heparin and stimulate the growth of a variety of different cell types. Demonstration of expression of receptors for various FGFs may help elucidate the involvement of FGFs in CNS development. Because a significant portion ofgrowth factor receptors isolated to date are PTKs, it seemed reasonable to assume that many unidentified PTKs may be involved in the pivotal events controlling growth and differentiation of the developing CNS. In addition, the receptors for the FGF family of ligands may belong to this receptor group.
Several approaches have been used to clone members of the protein kinase family, including the screening of cDNA libraries with DNA probes derived from sequences of conserved regions of the protein kinase catalytic domain (21) and the use of antiphosphotyrosine antibodies to screen cDNA expression libraries (22) (23) (24) . The polymerase chain reaction (PCR) technique was used to amplify a 200-base-pair (bp) region that lies between two highly conserved motifs within the catalytic domain of the PTKs (25) . We have detected among 200 independent PTK clones isolated in this way, five previously undescribed and 10 previously described PTKrelated sequences in cDNA made from E10 neuroepithelial cells.
We report the structure of two cDNAs clones § isolated from murine E10 neuroepithelial cells and immortalized neuroepithelium cell lines (14) . We show that these clones represent murine mRNAs similar to the putative chicken basic FGF receptors (bFGF-R) (26) . These cDNA clones are members of a family of genes that has at least four members.
MATERIALS AND METHODS
Analysis of RNA and DNA. Poly(A)+ RNA was prepared as described by Gonda et al. (27) . Samples of 2 ,ug were fractionated on a 1% agarose/formaldehyde gel and transferred onto nitrocellulose Hybond C-extra (Amersham) as described (28) . DNA was prepared from 5 x 106 cells by lysis with guanidine hydrochloride (29) and analyzed by Southern blot hybridization (30) .
DNA Amplification. DNA amplification was essentially as described by Wilks (25) . Poly(A)+ RNA from E10 mouse neuroepithelial cells (5 ,ug) (14) . The E10 neuroepithelial cell library was prepared using an oligo(dT)-Xba-primed cDNA kit with AGEM4 vector (Promega). The NZen37 library was constructed using a random-primer cDNA cloning kit (Amersham) together with a specific bFGF-R oligonucleotide 5'-GGTCGCCCCTAGGAGTCCC-TCGAG-3' corresponding to positions 1447-1470 ( Fig. 1 ) and cloned into AgtlO. Initially, -7 x 105 clones of the E10 cDNA library were screened with the 200-bp PTK fragment amplified by PCR from the M13 clone containing the PTK of interest. Inserts from recombinant clones were subcloned after removing the pGEM-1 plasmid of AGEM4 by digestion with Spe I and religation. For isolation of the 5' end of the cDNA clones, a 400-bp EcoRI-Acc I fragment from close to the 5' end of the E10 cDNA clone R2.1 (nucleotides 1414-3426) was used to screen -3 x 105 clones of the randomprimed NZen37 cDNA library. Inserts from recombinant clones were first subcloned into EcoRI-digested pGEM 3Zf(+) (Promega) and subsequently cloned into EcoRIcleaved M13mpl8 for sequencing. To obtain longer cDNA clones we also applied the "RACE" modification of the PCR technique (33) . Full-length cDNA clones were constructed by ligating the EcoRI-BamHI fragment comprising the 5' end of the cDNA to a BamHI-Xba I fragment containing the 3' end of the cDNA including the poly(A) tail. DNA fragments were labeled with deoxyadenosine [a-32P]triphosphate by using a random-hexamer-priming kit (Bresatec, Adelaide, South Australia).
In Vitro Translation. Full-length cDNA clones of both N-bFGF-R and bFGF-R were subcloned into the EcoRI and Xba I sites of the DAMP56 expression vector that is a modification of CDM8 (34 contained PTK-related sequences, whereas the other clones contained sequences unrelated to PTKs. The clones containing known PTK sequences were as follows: insulin-like growth factor receptor (36) , the murine hemopoietic cell kinase (37), c-abl (7) and c-src (6) . Two unusual PTK-related sequences were specific to E10 neuroepithelial cells; we designate these PTKs as NE2 and NE3. These cDNA clones are coding for closely related proteins. Of the 65 amino acids in the conserved PTK domain, only 5 amino acids differ between the two proteins (92% homology). These PTKs are closely related to FLG (32) and bek (38) . NE3 has an identical amino acid sequence to that of bek (38) . Having completed this work we have learned that NE2 and FLG (32) sequences are closely related to the chicken bFGF-R and are presumed to be the mouse and human bFGF receptors, respectively.
Two Different bFGF-R-like mRNAs. Intriguingly, two species of closely related cDNA clones were isolated by using the procedures described above. The longest clone has an open reading frame of 822 amino acids and is closely related to the previously published chicken sequence of bFGF-R (26) . This clone will henceforth be referred to as the murine bFGF-R. The second species of cDNA isolated, comprising 75% of the bFGF-R clones, has an identical sequence to that of the bFGF-R except that it has a deletion of 267 bp corresponding to 89 amino acids in the extracellular domain (shaded region in Fig. 1 ). These shorter cDNA clones were isolated from the NZen37 library and by the RACE technique. Sequence Analysis of bFGF-R. Comparison of the putative mouse bFGF-R with the chicken bFGF-R sequences revealed an overall identity of 91% at the amino acid level. A likely initiation methionine is located at position 58 followed by a stretch of 20 amino acids that is hydrophobic in character and probably represents a leader sequence (Fig. 1) . No in-frame ATG sequences were found in the 500 nucleotides 5' to the methionine of position 58. The region absent in the shorter bFGF-R clone has a much less identity (80%) with the chicken mRNA. In contrast, the region downstream from the deletion and the beginning of the transmembrane segment has 93% homology with chicken bFGF-R. If the two forms of the receptor predicted from these sequences have a common binding site, this site must lie on the carboxyl side of amino acid 118. A high level of identity is also seen within the tyrosine-kinase domain, where the homology is 98%.
Another region with less identity to the chicken sequences is the most-3' region adjacent to the termination codon. Of 15 amino acids, 8 differed between the mouse and the chicken, with 1 amino acid being deleted in the chicken bFGF-R. When this region is compared with the human bFGF-R (FLG), only a difference in two amino acids is seen. Threonine is changed to alanine at position 812 from the change in one nucleotide from adenine to guanine (Fig. 1) . Ser-817 is replaced by glycine, also as a result of a one-nucleotide change (from an adenine to a guanine). Amino acids 148 and 149 are sometimes deleted from the shorter mouse bFGF-R clones. Of 8 clones sequenced, 2 lack these amino acids. Possibly this region is a miniexon. Alternatively, there may be exons containing two splice acceptor sites or two splice donor sites close to each other such that the region is sometimes spliced out in the shorter transcripts. Interestingly, in the chicken bFGF-R gene a codon for one of these amino acids is missing. Proc. Nati. Acad. Sci. USA 87 (1990) Nucleotide sequence and deduced amino acid sequence of bFGF-R. Numbers at right indicate positions of nucleotides, and numbers above amino acids refer to the amino acid sequence. Underlined regions indicate the presumed signal peptide and transmembrane regions, respectively. Underlined amino acids (126-133) indicate a stretch of acidic residues. The shaded region between the two arrows represents the region deleted in N-bFGF-R mRNA. Dots indicate possible sites of N-glycosylation (N-X-S/T), asterisks indicate the ATP-binding site, and the arrow above tyrosine identifies the putative site of autophosphorylation. Bold letters above the amino acid sequence indicate amino acids that differ between chicken and mouse bFGF-R, whereas bold letters below the nucleotide sequence (amino acids 812 and 817) are amino acids from human bFGF-R (FLG) (32) that differ from mouse bFGF-R in this region.
Southern Blot Analysis. It is apparent from Southern blot like molecules were isolated using the PCR reaction (data not analysis (Fig. 2) hybridization using poly(A)+ RNA from different mouse tissues, from mouse brain during embryonic development, and from several murine cell lines (Fig. 3) . The highest expression was seen in mouse brain and in cell lines derived from mouse E10 neuroepithelium, NZen37 (14) and 2.3D (39).
Only very low levels of bFGF-R mRNA are expressed in thymus, heart, and spleen. Expression of bFGF-R is seen in E10 mouse neuroepithelium (data not shown) and continues to be expressed in adult mouse brain. Although the two forms of the bFGF-R differ only in 267 bp and are not well resolved on the RNA blot, the data are consistent with the idea that the two forms of the receptor are expressed by these cells (Fig.  3) . Addition of bFGF to 2.3D cells 24 and 72 hr before preparation of the poly(A)+ RNA did not alter the expression of bFGF-R mRNA. bFGF-R is also expressed in a neural crest cell line, the neuroblastoma N2A, and a teratocarcin-L-^h noma (tera-2), T2 NZen6, a T2 cell line producing N-myc retrovirus (14) , also expressed low levels of bFGF-R.
Translation in Vitro of the Two bFGF-R cDNA Clones. Full-length cDNA clones of bFGF-R and its shorter version were subcloned into the DAMP 56 vector. The cDNA was transcribed using T7 polymerase and then translated in rabbit reticulocyte lysates. Fig. 4 demonstrates the translation products of the two cDNAs. The bFGF-R cDNA clone was translated into a protein of '100 kDa, whereas the shorter gene was translated into a protein of an approximate molecular mass of 85 kDa. The difference in molecular masses is consistent with the 89-amino acid deletion predicted from cDNA sequences. The molecular mass of the in vitro translation product is much smaller than the native molecule (145 kDa) (41) , most probably because of lack of glycosylation.
DISCUSSION
We have described the isolation of two bFGF-R-like genes from a cDNA library constructed with mouse E10 neuroepithelium mRNA and NZen37 mRNA. Two variant cDNA clones from the NZen37 cDNA library coding for two forms of bFGF-R, namely, the bFGF-R and the shorter version designated N-bFGF-R, were sequenced. The two cDNA clones are identical, except for a 269-bp insert near the 5' terminus, and were most probably transcribed from the same gene. Because of the very high amino acid sequence identity with the chicken bFGF-R (26), we believe that these clones encode two forms of the mouse bFGF-R. The shorter bFGF-R-like mRNA is designated N-bFGF-R because it was isolated from neural tissue and is identical to bFGF-R, except for a deletion of 89 amino acids from amino acids 31-118. Probably this deletion has arisen by a differential splicing mechanism.
Lee et al. (26) suggested that chicken bFGF-R belongs to the immunoglobulin supergene family (42) . The chicken bFGF-R has three of the characteristic immunoglobulin-like domains containing two cysteine residues, which are common to this superfamily. These cysteine residues are also conserved in the mouse bFGF-R. In many of the immunoglobulin superfamily genes, such as PolylgR (43) ulin-related domain is encoded by one exon. The deleted region in the N-bFGF-R cDNA corresponds to an immunoglobulin-related domain and may therefore be encoded by one exon.
N-bFGF-R could be a receptor for acidic FGF (aFGF) because aFGF has been shown to bind to the bFGF-R and to bind with higher affinity to a receptor of 125 kDa that is -20 kDa smaller than the bFGF-R (41); this is approximately the difference in molecular mass between bFGF-R and its shorter counterpart, N-bFGF-R, when possible posttranslational modifications are considered.
Lee et al. (26) have previously suggested that the mouse tyrosine kinase bek (32) might be the mouse bFGF-R. However, because 85% amino acid identity exists between mouse bFGF-R and the chicken bFGF-R in the catalytic domain compared with 98% identity between the gene we have isolated and the chicken sequence, the larger cDNA clone we have isolated is probably the mouse bFGF-R, whereas bek is another gene belonging to the same family. Our data also indicate that bFGF-R belongs to a multigene family (Fig. 2 ) that most probably encodes receptors binding to the other members of the FGF family, such as aFGF (15), int-2 (17), hst (16) , , keratinocyte growth factor (19) , and FGF-6 (20) . We have demonstrated here that the tyrosine kinase domain is highly conserved between the members of this family while the extracellular portion differs; hybridization with a tyrosine kinase domain probe yielded additional bands on the Southern blots that were not seen after hybridization with a probe from the extracellular domain of the bFGF-R cDNA (Fig. 2) . These Southern blot data are supported by the subsequent isolation of two additional FGF-like receptors by the PCR reaction with PTK-I and PTK-II oligonucleotides. One of these receptors has an identical tyrosine kinase domain sequence to bek (NE3) and the other, the NE5 cDNA (data not shown), has a very high level of homology with mouse bFGF-R and bek. Although a high level of identity is seen in the intracellular domain outside the tyrosine kinase domain, we do not yet know whether the homology also extends to the extracellular domain of the receptors. We have also isolated additional protein kinase sequences from the E10 neuroepithelium cDNA, including three members of the Thr/Ser kinase family also expressed in WEHI-3B cells (46) (D06, D14, and D16; data not shown). Two PTKs, JAKi and JAK2 (25) , and a putative growth factor receptor, BM13, are also expressed in hemopoietic and epithelial cells (data not shown). Two putative growth factor receptors (NE1 and NE5) and one src-like PTK were also identified only in E10 neuroepithelium cDNA (data not shown).
The isolation of different members of the FGF-R family from neuronal tissues of the developing mouse embryos suggests that FGF-like molecules other than bFGF may play an important role in development of the CNS. Isolation of the bFGF-R cDNA and the shorter N-bFGF-R cDNA from E10 neuroepithelium and from immortalized neuroepithelial cell lines is a first step in determining whether bFGF-R and N-bFGF-R, together with their ligands, are important in regulating growth and differentiation of E10 mouse neuroepithelium.
